Process evaluation of an implementation strategy to support uptake of a tuberculosis treatment adherence intervention to improve TB care and outcomes in Malawi.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
02 07 2021
Historique:
entrez: 3 7 2021
pubmed: 4 7 2021
medline: 5 8 2021
Statut: epublish

Résumé

To assess implementation and to identify barriers and facilitators to implementation, sustainability and scalability of an implementation strategy to provide lay health workers (LHWs) with the knowledge, skills and tools needed to implement an intervention to support patient tuberculosis (TB) treatment adherence. Mixed-methods design including a cluster randomised controlled trial and process evaluation informed by the RE-AIM framework. Forty-five health centres (HCs) in four districts in the south east zone of Malawi, who had an opportunity to receive cascade training. Forty-five peer-trainers (PTs), 23 patients and 20 LHWs. Implementation strategy employing peer-led educational outreach, a clinical support tool and peer support network to implement a TB treatment adherence intervention. Process data were collected from study initiation to the end-of-study PT meeting, and included: LHW and patient interviews, quarterly PT meeting notes, training logs and study team observations and meeting notes. Data sources were first analysed in isolation, followed by method, data source and analyst triangulation. Analyses were conducted independently by two study team members, and themes revised through discussion and involvement of additional study team members as needed. Forty-one HCs (91%) trained at least one LHW. Of 256 LHWs eligible to participate at study start 152 (59%) completed training, with the proportion trained per HC ranging from 0% to 100% at the end of initial cascade training. Lack of training incentives was the primary barrier to implementation, with intrinsic motivation to improve knowledge and skills, and to improve patient care and outcomes the primary facilitators of participation. We identified important challenges to and potential facilitators of implementation, scalability and sustainability, of the TB treatment adherence intervention. Findings provide guidance to scale-up, and use of the implementation strategies employed, to address LHW training and supervision in other areas. NCT02533089.

Identifiants

pubmed: 34215610
pii: bmjopen-2020-048499
doi: 10.1136/bmjopen-2020-048499
pmc: PMC8256754
doi:

Banques de données

ClinicalTrials.gov
['NCT02533089']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e048499

Subventions

Organisme : CIHR
ID : KAL-139700
Pays : Canada

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Niger J Med. 2014 Apr-Jun;23(2):103-17
pubmed: 24956684
BMC Health Serv Res. 2016 May 03;16:164
pubmed: 27142944
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Hum Resour Health. 2018 May 8;16(1):22
pubmed: 29739394
BMC Health Serv Res. 2020 Jun 5;20(1):513
pubmed: 32503525
BMC Int Health Hum Rights. 2011 Nov 08;11 Suppl 2:S11
pubmed: 22166125
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Trials. 2016 Sep 07;17(1):439
pubmed: 27604571
Int Nurs Rev. 2008 Sep;55(3):265-73
pubmed: 19522941
Public Health Nutr. 2016 Jul;19(10):1882-92
pubmed: 26370070
Cochrane Database Syst Rev. 2010 Mar 17;(3):CD004015
pubmed: 20238326
Implement Sci. 2020 Dec 11;15(1):107
pubmed: 33308257
Int J Tuberc Lung Dis. 2012 Nov;16(11):1492-7
pubmed: 22964096
PLoS One. 2018 Aug 30;13(8):e0203265
pubmed: 30161213
Hum Resour Health. 2018 Aug 16;16(1):39
pubmed: 30115074
BMC Health Serv Res. 2014;14 Suppl 1:S8
pubmed: 25080192
Health Policy Plan. 2015 Nov;30(9):1207-27
pubmed: 25500559
BMC Med Educ. 2016 Feb 09;16:54
pubmed: 26861834
J Acquir Immune Defic Syndr. 2011 Aug;57 Suppl 2:S109-12
pubmed: 21857292
Cochrane Database Syst Rev. 2013 Oct 08;(10):CD010414
pubmed: 24101553
PLoS One. 2019 May 31;14(5):e0217617
pubmed: 31150458
Implement Sci. 2015 Mar 28;10:38
pubmed: 25890186
BMC Health Serv Res. 2018 Mar 13;18(1):177
pubmed: 29534729

Auteurs

Lisa M Puchalski Ritchie (LM)

Department of Medicine, University of Toronto, Toronto, Ontario, Canada lisa.puchalskiritchie@utoronto.ca.
Knowledge Translation Program, St Michael's Hospital Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada.
Emergency Medicine, University Health Netowrk, Toronto, Ontario, Canada.
Institute of Health policy, management, and evaluation, university of toronto, toronto, ontario, canada.

Esther C Kip (EC)

Dignitas International, Zomba, Malawi.

Hayley Mundeva (H)

Knowledge Translation Program, St Michael's Hospital Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada.

Monique van Lettow (M)

Dignitas International, Zomba, Malawi.
University of Toronto Dalla Lana School of Public Health, Toronto, Ontario, Canada.

Austine Makwakwa (A)

Malawi National TB control Program, Lilongwe, Malawi.

Sharon E Straus (SE)

Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Knowledge Translation Program, St Michael's Hospital Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada.

Jemila S Hamid (JS)

Department of Mathematics and Statistics, University of Ottawa, Ottawa, Ontario, Canada.

Merrick Zwarenstein (M)

Family Medicine, Schulich School of Medicine and Dentistry Department of Family Medicine, London, Ontario, Canada.

Michael J Schull (MJ)

Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Adrienne K Chan (AK)

Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Alexandra Martiniuk (A)

The George Institute for Global Health, Newtown, New South Wales, Australia.
The University of Sydney, Sydney, New South Wales, Australia.

Vanessa van Schoor (V)

Dignitas International, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH